Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Slides:

Advertisements

Similar presentations

Elizabeth A. David, MD, David T

Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database Daniel J. Boffa,

The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes Felix G. Fernandez, MD, MS, Andrzej S. Kosinski,

Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption Justin D. Blasberg, MD, Christopher W. Seder,

Chun Chieh Lin, PhD, MBA, Matthew P

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Postoperative Atrial Fibrillation Prophylaxis After Lung Surgery: Systematic Review and Meta-Analysis Lars Peter Riber, MD, PhD, Torben Bjerregaard Larsen,

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Harm H. H. Feringa, MD, Leslee J

Feasibility and Safety of Nonintubated Thoracoscopic Lobectomy for Geriatric Lung Cancer Patients Chun-Yu Wu, MD, Jin-Shing Chen, MD, PhD, Yi-Shiuan.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Castigliano M. Bhamidipati, DO, MS, George J

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Lung Cancer Surgery in Patients With Liver Cirrhosis

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Joshua E. Rosen, BASc, Jacquelyn G. Hancock, BS, Anthony W

Thomas J. Birdas, MD, Richard P. M

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J

Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Lung Function and ECMO After Lung Transplantation

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Christopher W. Seder, MD, Cameron D. Wright, MD, Andrew C

Distribution and Likelihood of Lymph Node Metastasis Based on the Lobar Location of Nonsmall-Cell Lung Cancer Robert J. Cerfolio, MD, Ayesha S. Bryant,

Raymond U. Osarogiagbon, MBBS, Meredith A. Ray, MPH, PhD, Nicholas R

The Annals of Thoracic Surgery

Specialty Training and Mortality After Esophageal Cancer Resection

Use of a Surgical Specimen-Collection Kit to Improve Mediastinal Lymph-Node Examination of Resectable Lung Cancer Raymond U. Osarogiagbon, MBBS, FACP,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Sagar U. Nigwekar, MD, Praveen Kandula, MD, MPH

Yinin Hu, MD, Timothy L. McMurry, PhD, Kristen M. Wells, PhD, James M

The Society of Thoracic Surgeons Composite Score for Rating Program Performance for Lobectomy for Lung Cancer Benjamin D. Kozower, MD, MPH, Sean M. O’Brien,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M

Induction Therapy Followed by Surgery for T3-T4/N0 Non-Small Cell Lung Cancer: Long-Term Results Filippo Lococo, MD, Alfredo Cesario, MD, Stefano Margaritora,

Presentation transcript:

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U. Osarogiagbon, MBBS, Obiageli Ogbata, MBBS, Xinhua Yu, MD, PhD The Annals of Thoracic Surgery Volume 97, Issue 2, Pages 385-393 (February 2014) DOI: 10.1016/j.athoracsur.2013.09.058 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Selection of study cohort. The Annals of Thoracic Surgery 2014 97, 385-393DOI: (10.1016/j.athoracsur.2013.09.058) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Distribution of number of lymph nodes examined in patients with resected pathologic node-negative non–small cell lung cancer (NSCLC): US Surveillance, Epidemiology and End Results database, 1998 to 2009. The Annals of Thoracic Surgery 2014 97, 385-393DOI: (10.1016/j.athoracsur.2013.09.058) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Evolution of hazard ratio for mortality with the number of lymph nodes examined. (A) All-cause mortality. (B) Lung cancer–specific mortality. (CI = confidence interval.) The Annals of Thoracic Surgery 2014 97, 385-393DOI: (10.1016/j.athoracsur.2013.09.058) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Evolution of hazard ratio for all-cause mortality with the number of lymph nodes examined in lobectomy cases. (CI = confidence interval.) The Annals of Thoracic Surgery 2014 97, 385-393DOI: (10.1016/j.athoracsur.2013.09.058) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Trend analysis of the number of lymph nodes examined in resected pathologic node-negative non–small cell lung cancer (NSCLC): US Surveillance, Epidemiology and End Results database, 1998 to 2009. The Annals of Thoracic Surgery 2014 97, 385-393DOI: (10.1016/j.athoracsur.2013.09.058) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions